I
IntegraGen
Biotech & Life Sciences · Évry-Courcouronnes, France · Founded 2000
Leader in genome analysis and molecular diagnostics for oncology and autism MoreLess
IntegraGen specializes in genome analysis and the development of molecular diagnostic tests, focusing on oncology and autism. The company operates in the healthcare and biotechnology sectors, serving clinical and research laboratories. IntegraGen's business model revolves around providing genomic services, including high throughput sequencing and bioinformatics, to help researchers and clinicians analyze genomic data. The company generates revenue through the commercialization of its molecular diagnostic tests and genomic services. By identifying novel genetic biomarkers, IntegraGen aims to translate molecular research into clinical practice, aiding in treatment decisions and advancing personalized medicine.
Keywords: genome analysis, molecular diagnostics, oncology, autism, high throughput sequencing, bioinformatics, genetic biomarkers, clinical practice, personalized medicine, genomic services.
Talent graph
IntegraGen's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where IntegraGen has talent and traffic
team presence
Market sentiment
What the market is saying about IntegraGen
An AI-synthesized read of the highest-engagement posts about IntegraGen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IntegraGen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.